Moreover, SIRT3 overexpression resulted in increased level of phosphorylated-c-Jun and Bim which is downstream target of AP-1 in HCC cells exposed to chemotherapeutic agents (Figure 5C–5E). This evidence concerns the gene BCL2L11 and hepatocellular carcinoma.